2018
DOI: 10.1016/j.fsi.2018.01.029
|View full text |Cite
|
Sign up to set email alerts
|

Novel subunit vaccine with linear array epitope protect giant grouper against nervous necrosis virus infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(15 citation statements)
references
References 39 publications
0
13
0
Order By: Relevance
“…Another strategy for NNV vaccine development has been the use of subunit vaccines [163]. The latest studies include viral protein expression in recombinant yeast Sacharomyces cerevissae [333] or tobacco chloroplasts [334] as well as in Escherichia coli [335] and the use of a linear array epitope (LAE) technique [336]. The expression of the viral protein as virus-like particles (VLPs) has also been achieved in the yeast Yarrowia lipolytica [337].…”
Section: Preventionmentioning
confidence: 99%
See 2 more Smart Citations
“…Another strategy for NNV vaccine development has been the use of subunit vaccines [163]. The latest studies include viral protein expression in recombinant yeast Sacharomyces cerevissae [333] or tobacco chloroplasts [334] as well as in Escherichia coli [335] and the use of a linear array epitope (LAE) technique [336]. The expression of the viral protein as virus-like particles (VLPs) has also been achieved in the yeast Yarrowia lipolytica [337].…”
Section: Preventionmentioning
confidence: 99%
“…Protection conferred by recombinant-protein vaccines has been reported to be high, i.e., vaccinated giant grouper RPS values above 72% [336] and increasing up to more than 80% in Atlantic sea bass [340]. Recently, total protection has been claimed in vaccinated convict/seven band grouper and European sea bass [335,341].…”
Section: Preventionmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, nervous necrosis virus (NNV) VLP vaccines that utilized E. coli , yeast, baculovirus, and plant or cell-free self-assembled expression were produced. Those studies showed that VLPs with similar size and geometry to the native virus could elicit an antibody response in fish by injection [103,104,105,106,107,108]. Chien et al and Cho et al developed oral VLP vaccines against grouper NNV [109,110].…”
Section: Alternative Vaccine Technologymentioning
confidence: 99%
“…Vaccination is one of the most effective interventions and innovative strategies for research, and development of vaccines must be encouraged in aquaculture (Kai et al., 2014; MacLachlan & Dubovi, 2016). Although there is an effort to develop vaccines for grouper against NNV in Taiwan, commercial application is still not established due partly to the lack of a cheaper manufacturing process and effective protection (Lin, Jiang, Chen, Wang, & Chen, 2018). Hence, to provide insight into the development of NNV vaccination programme, we tended to apply the transmission dynamic models to evaluate the effectiveness of vaccination.…”
Section: Introductionmentioning
confidence: 99%